These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5005311)

  • 41. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reactivities of various mycobacteria species against DNA probes (Gen-Probe Rapid Diagnostic System) specific to Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare].
    Tomioka H; Sato K; Saito H; Tasaka H
    Kekkaku; 1991 Jun; 66(6):405-11. PubMed ID: 1942722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The sensitization of children by opportunist mycobacteria in Lagos, Nigeria.
    Ogunmekan DA
    J Hyg (Lond); 1978 Jun; 80(3):321-5. PubMed ID: 418112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Original Mycobacterial Sin, a consequence of highly homologous antigens?
    Jenkins AO; Michel A; Rutten V
    Vet Microbiol; 2017 May; 203():286-293. PubMed ID: 28619159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative immunogenicity of streptomycin-susceptible and -resistant strains of BCG. II. Effect of the route of inoculation on growth and immunogenicity.
    Collins FM; Montalbine V
    Am Rev Respir Dis; 1975 Jan; 111(1):43-51. PubMed ID: 1089372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination of cattle with a high dose of BCG vaccine 3 weeks after experimental infection with Mycobacterium bovis increased the inflammatory response, but not tuberculous pathology.
    Buddle BM; Shu D; Parlane NA; Subharat S; Heiser A; Hewinson RG; Vordermeier HM; Wedlock DN
    Tuberculosis (Edinb); 2016 Jul; 99():120-127. PubMed ID: 27450013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice.
    Collins FM; Mackaness GB
    Cell Immunol; 1970 Sep; 1(3):253-65. PubMed ID: 5002229
    [No Abstract]   [Full Text] [Related]  

  • 52. Tuberculin hypersensitivity following BCG vaccination in Brisbane school children.
    Abrahams EW
    Tubercle; 1979 Jun; 60(2):109-13. PubMed ID: 112744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guérin.
    Daugelat S; Ladel CH; Kaufmann SH
    Infect Immun; 1995 May; 63(5):2033-40. PubMed ID: 7537253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    Orme IM; Collins FM
    J Immunol; 1983 Sep; 131(3):1452-4. PubMed ID: 6411817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.
    Shepard CC; Van Landingham R; Walker LL
    Infect Immun; 1976 Oct; 14(4):919-28. PubMed ID: 11189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
    Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.